Possibilities
While we are actively advancing this research, we acknowledge that some aspects, such as CRISPR and mRNA-based therapies, represent the direction we are striving toward but have not yet fully realized.
01
CRISPR-Based Gene Editing (Future Focus)
The potential of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a key area of interest for Alercell
02
Advanced Diagnostics
Alercell leverages innovative technologies, including DNA sequencing and liquid biopsy, to deliver precise and rapid detection of genetic mutations and biomarkers associated with cancer. This foundational work is critical to guiding future therapeutic strategies.
03
Using AI, Alercell can predict the likelihood of disease progression and treatment response by analyzing genetic markers and patient-specific data. This predictive capability supports proactive and preventive care strategies
04
mRNA-Based Therapeutics (Future Focus)
Alercell is exploring the application of mRNA technology for cancer treatment. Future therapeutic possibilities include:
05
Our ultimate goal is to deliver treatment regimens tailored to individual genetic and molecular profiles, minimizing trial-and-error and enhancing treatment efficacy.
06
Preventive Applications
Alercell aims to leverage its diagnostic expertise to detect precancerous conditions and genetic predispositions, enabling interventions that could prevent cancer development entirely.
Where we are today
The Lena DX Leukemia Platform
A comprehensive suite of 12 advanced genetic tests designed to provide a detailed understanding of each patient’s condition.
Generic Testing
Alercell is redefining cancer diagnostics and empowering a new era in precision medicine.
